Q2 2026 earnings call recap: record purchase volume, raised EPS guide, NIM/late-fee outlook, credit and capital return.

ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.

Even as Cadillac expands its electric vehicle lineup, the luxury automaker appears poised to keep its high-performance ...

Ashlins Pharmaceuticals today announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc., has entered into an exclusive license and supply agreement with Lee’s Pharmaceutical ...

The Genius Wave launches 12-minute theta audio as peer-reviewed research links theta brainwaves to creativity and ...

The State of Indiana has opted out of the SUN Bucks program for the second year, which Democratic state leaders and educators ...

Even more than access to alternative assets and simplified platforms, advisors are looking to outside account providers to ...

The HudsonAlpha Institute for Biotechnology has been awarded an initial $15 million, with the potential for up to $160 ...

Alpha Sigma Tau’s Zeta Chapter at Commonwealth University-Lock Haven was recently recognized by the National Organization for ...

Saronic Technologies Inc. has picked South Texas as the site of its $3.2 billion Port Alpha, the high-tech shipyard where it ...

"Alpha Gang," "Glaxo," "The Housewife," "Love of Your Life" and "Your Mother Your Mother Your Mother" have been added to the festival lineup.